Expert Consensus on the Clinical and Economic Value of Advanced Wound-Care Products in Mexico: Results From a Delphi Panel

Author(s)

Alejandro Grimaldi Ferreira, MS1, Marc Valls, MS1, Jimena Iglesias, MD2, Christian Castillo Quiroz, BS3, Priscila Cantú, MD3.
1TIS, Miguel Hidalgo, Mexico, 2Sináptica RWE, Mexico City, Mexico, 3Essity, Mexico City, Mexico.
OBJECTIVES: To gather insights based on expert consensus regarding the clinical, economic, and operational benefits associated with various wound care materials used for wound management and intravenous device fixation, from the perspective of healthcare professionals in Mexico. Specifically, the focus was on infection prevention, antibiotic use, exudate management, wound healing, dressing adhesion and durability, and the economic implications in terms of resource utilization.
METHODS: A real-time Delphi Panel was conducted with a final sample of 12 healthcare professionals experienced in wound care. The consensus was reached during a 2-hour virtual session, in which pre-survey responses were openly discussed and analyzed in a moderated format.
RESULTS: Based on expert consensus, dialkylcarbamoyl chloride (DACC)-coated dressings (specifically Cutimed® Sorbact® for chronic wounds and Leukomed® Sorbact® for postsurgical wounds) were reported to be highly effective in reducing infections caused by multidrug-resistant pathogens. This was associated with reduced need for systemic antibiotics and more efficient antimicrobial treatment duration. The hydroactive absorbent dressing Cutimed® Sorbion® was recognized for superior absorption capacity compared to alginates, hydrocellular foams, and hydrocolloids, supporting better exudate control and lowering the risk of periwound maceration. Regarding adhesion performance, the elastic polyester adhesive tape Hypafix® was identified as the most durable solution for device fixation, with an average wear time of 6.3 days and up to 7 days without replacement, contributing to reduced resource use. The polyurethane adhesive film Leukomed® IV demonstrated superior adherence and stability by day three of application compared to other similar dressings.
CONCLUSIONS: This study reflects a high level of expert consensus on the clinical and operational benefits of these products in wound care and vascular access fixation, particularly in infection reduction, improved exudate management, and enhanced dressing adhesion and durability.

Conference/Value in Health Info

2025-11, ISPOR Europe 2025, Glasgow, Scotland

Value in Health, Volume 28, Issue S2

Code

CO116

Topic

Clinical Outcomes, Health Service Delivery & Process of Care, Medical Technologies

Topic Subcategory

Performance-based Outcomes

Disease

Injury & Trauma

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×